Article

P17 Letrozole (2.5 mg o.d.) is superior to anastrozole (1.0 mg o.d.) concerning suppression of both plasma and tissue estrogen levels in postmenopausal breast cancer patients

JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE, LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
The Breast (Impact Factor: 2.58). 03/2007; 16:S17. DOI: 10.1016/S0960-9776(07)70082-6
1 Follower
 · 
73 Views